AC Immune SA (ACIU)

[FALCON1]

WOW! 3 consecutive prs recently. This is getting more eyes watching!
Its not a surprise when one day AC Immune will be acquired, in my opinion.

regards

[FALCON1]

AC Immune Announces Important Clinical Milestones for ACI-24 Vaccine in Alzheimer's Disease and Down Syndrome

* Start of Phase 2 trial with ACI-24 in patients with mild Alzheimer's disease; first patient enrolled
* Recruitment completed for high-dose cohort of Phase 1b study with ACI-24 for Abeta-related cognitive decline in individuals with Down Syndrome

ACI-24 Vaccine for Alzheimer's Disease
AC Immune has started the Phase 2 study with ACI-24 in patients with mild Alzheimer's disease (AD). The aim of this double-blind, randomized, placebo-controlled study with an adaptive design is to assess the safety, tolerability, immunogenicity, target engagement, biomarkers and clinical efficacy of ACI-24. The trial will seek to confirm the positive trends on Abeta PET* imaging and clinical measurement (CDR-SB°) of the previous Phase 1 safety study. The Phase 2 trial will be conducted in several European countries and the first patients have been screened.

ACI-24 in Down Syndrome
AC Immune has completed recruitment for the high-dose cohort of the ACI-24 Phase°1b study for the treatment of Alzheimer's disease-like characteristics in adults with Down Syndrome (DS), a condition affecting approximately one in 700 newborns. The first low-dose and the second high-dose cohorts have been fully recruited in August 2017 and in July 2018 respectively, and interim results of the low dose cohort are expected later in 2018. In addition to cognitive dysfunction beginning in childhood, individuals with DS are genetically-predisposed to develop Abeta-related cognitive decline at a much younger age and with much greater probability than the general population.

http://ir.acimmune.com/phoenix.zhtml?c=254264&p=irol-news&nyo=0

[novicetrader]

ACIU is getting back on track looks like,up nicely today(9%).

[novicetrader]

Bought some @9.75 today.Odd that it was nicely up above $10 for most part of the day,then trailed down.Low floater,wide Bid/Ask gaps,hopefully will do well when volume comes in.

[FALCON1]

You're right. Oversold! on Positive data even??? Truly laughable! AC Immune and partners Genentech/Roche is in full steam in the race to treat and prevent AD. https://www.acimmune.com/ <<< DDs here!

[novicetrader]

Is this 2 day drop overdone?It's now much below the recent $11.75 share offering price(had thought that would've been the floor).It had probably gone up on the hype,but isn't this drop looking overdone,that too when it's not on company-specific news,but just in sympathy with BIIB?
Would like to hear thoughts of those who've followed this company ,the science,and the Alzheimer's disease group.Thanks

[FALCON1]

WOW! Awesome move today! Next week's sentiment should be interesting considering the upcoming company/partners presentation in Chicago. More eyes are noticing this gem! THE RACE TO TREAT/PREVENT ALZHEIMER'S DISEASE IS ON!!!

[FALCON1]

AC Immune (NASDAQ: ACIU) MILESTONES/HISTORY

2018
Genentech milestone payment 3 (anti-Tau antibody)

2017
Essex Bio-Technology research collaboration for neurodegenerative diseases and neuroinflammation

2016
INITIAL PUBLIC OFFERING (IPO) on NASDAQ

2016
Genentech milestone payment 2 (anti-Tau antibody)

2016
Biogen research and development collaboration for diagnostics in neurodegenerative diseases

2015
Nestlé Institute of Health Science research collaboration for Tau diagnostic assay

2015
Genentech milestone payment 3 (crenezumab)

2015
Genentech milestone payment 1 (anti-Tau antibody)

2015
Janssen Pharmaceuticals licensing agreement for anti-Tau therapeutic vaccine ($509 million)

2014
Piramal Imaging licensing agreement for anti-Tau diagnostic (significant value)

2012
Genentech licensing agreements for anti-Tau antibody ($418 million)

2011
Genentech milestone payment 2 (crenezumab)

2009
E&Y Entrepreneur of the Year
WEF Technology Pioneer

2009
Bayer Schering collaboration for brain imaging taken over by Piramal Imaging

2008
Genentech milestone payment 1 (crenezumab)

2006
Genentech licensing agreements for anti-Abeta antibody ($300 million)

2003
Foundation of AC Immune


https://www.acimmune.com/en/history/

[FALCON1]

Awesome move last Friday. Yes, been quiet for long time. Good to see somebody around. I thought I'm alone here. lol

[jimmy667]

Stealth mode indeed. Not even “profiled” as a trade by Claytrader after the 38% spike on 7/6/18. Very quiet around here as well.

[FALCON1]

This is very well kept in stealth-mode. Great robust pipeline and partnerships. A potential M&A target, IMO.

https://www.acimmune.com/en/pipeline-overview/

lovin' that swiss :), patiently waiting to skyrocket!

Long&Strong

[FALCON1]

Awesome news today!
AC Immune prepares for a first in human study of a promising positron emission tomography (PET) tracer for Parkinson's diseas...

>>> First potential PET tracer for Parkinson's disease
>>> First in human study is scheduled for the second half of 2018
>>> AC Immune's lead compound is highly selective for alpha-synuclein - a key protein in Parkinson's disease pathology


This next generation tracer was discovered using the company's proprietary MorphomerTM chemistry technology platform. AC Immune has been successfully collaborating on this program with Biogen since April 2016. The companies will continue to further research, develop and clinically validate this alpha-synuclein PET tracer that will be used as an imaging biomarker for Parkinson's disease with an aim to enable the clinical development of new disease-modifying therapies. This project from AC Immune is being supported by The Michael J. Fox Foundation for Parkinson's Research (MJFF).

https://ih.advfn.com/p.php?pid=nmona&article=76951663

[FALCON1]

SEC form sc13g/a filed. Looking good!

[FALCON1]

Good NEWS! Today...AC IMMUNE COMPLETES RECRUITMENT FOR LOW-DOSE COHORT IN WORLD'S FIRST CLINICAL TRIAL FOR ANTI-ABETA VACCINE TARGETING ALZHEIM...


https://finance.yahoo.com/news/ac-immune-completes-recruitment-low-100553627.html

Exciting times ahead.

gotta luv swiss :)

[billmick11]

We are approaching the lowest price for ACIU for the year! Have the fundamentals really changed that much? I'm ready for the spigot to be opened on the pipeline! Go ACIU!

[FALCON1]

GOOD LUCK!

[T695]

On watch, probably won't jump in until after next earnings though

[FALCON1]

Added more today. Great pipeline.

[stocktrademan]

ACIU bearish 12.22



normal chart



log chart

[T695]

End of quiet period....should be interesting. Just took a stater position at $9.98

[T695]

On watch for entry. Solid fundamentals here

[FALCON1]

Wow! This is a beast! Unstoppable! $$$

[FALCON1]

Looking Good here $$$ :)

[FALCON1]

I got my Long Term position of 1000 shares here today. This newly-IPO biotech company has great pipeline with established partnership among the best companies in the pharma/biotech industry. I'm not surprise when this gets acquired in a short period of time, IMHO.

Good Luck